Dual crisis threatens Romania's air traffic control; national security at risk
Translated from Romanian, summarized and contextualized by DistantNews.
At a glance
- ROMATSA, Romania's air traffic control provider, faces a dual crisis threatening its operations and national security.
- A court decision suspended ROMATSA's air navigation service provider certificate due to an employment discrimination lawsuit.
- Simultaneously, Pfizer has blocked ROMATSA's accounts to recover funds related to Romania's COVID-19 vaccine purchase dispute.
Romania's air traffic control authority, ROMATSA, is grappling with an unprecedented crisis that jeopardizes its ability to manage national airspace and poses significant national security risks. Sorin Stoicescu, an aviation expert and former head of Civil Aviation, warns that if ROMATSA ceases providing air navigation services, it will lose revenue from Eurocontrol, potentially leading to a complete financial collapse.
The situation is compounded by a court ruling in March by the Bucharest Court of Appeal, which suspended ROMATSA's certificate as an air navigation service provider for 30 days. This decision stems from a lawsuit filed by 12 air traffic controllers alleging discrimination in hiring practices. Although ROMATSA plans to appeal and stated its operations continue normally, the potential consequences are severe. The Supreme Council of National Defense (CSAT) has urged the government to take urgent measures, highlighting that a suspension of ROMATSA's activities could create a major systemic vulnerability for national security, degrade airspace surveillance, and disrupt NATO missions on the Eastern Flank.
If ROMATSA no longer provides air navigation services, Eurocontrol will no longer transfer the associated funds, and the institution risks remaining without any source of income.
Furthermore, the operational blockage could force rerouting of European transit corridors and damage Romania's credibility as a regional security provider in its dealings with Eurocontrol. The Judicial Inspection has launched an investigation into the circumstances surrounding the court's decision. Adding to the crisis, ROMATSA's accounts were blocked on July 1st by Pfizer. This action is part of enforcement proceedings initiated by the pharmaceutical company against the Romanian state to recover over 3.4 billion lei and approximately 18.5 million euros. These sums are related to a legal dispute over Romania's purchase of COVID-19 vaccines.
A possible suspension of ROMATSA's activity would generate a major systemic vulnerability to national security, leading to immediate degradation of integrated airspace surveillance and disruption of NATO tactical or logistical missions on the Eastern Flank.
Originally published by Adevฤrul in Romanian. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.